37 filings
8-K
ALXO
Alx Oncology Holdings Inc
9 May 24
ALX Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update
4:05pm
8-K
ALXO
Alx Oncology Holdings Inc
2 May 24
Departure of Directors or Certain Officers
4:07pm
8-K
ALXO
Alx Oncology Holdings Inc
7 Mar 24
ALX Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
4:05pm
8-K
ALXO
Alx Oncology Holdings Inc
26 Dec 23
Entry into a Material Definitive Agreement
4:01pm
8-K
ALXO
Alx Oncology Holdings Inc
13 Nov 23
ALX Oncology Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:03pm
8-K
pwt3akgj6o0jzgr
6 Oct 23
ALX Oncology Announces Pricing of Public Offering
6:06am
8-K
ymrprr44
4 Oct 23
Results of Operations and Financial Condition
5:21pm
8-K
lje mj8zmw
4 Oct 23
Other Events
8:00am
8-K
c9ajvh7l 2wggn7xexe
6 Sep 23
Departure of Directors or Certain Officers
4:05pm
8-K
5yy7n6
10 Aug 23
ALX Oncology Reports Second Quarter 2023 Financial Results and Provides Clinical Program Update
4:05pm
8-K
8k98zc9vh5c
20 Jun 23
Amendments to Articles of Incorporation or Bylaws
8:45am
8-K
3iy976
11 May 23
ALX Oncology Reports First Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights
4:03pm
8-K
fxih2e spa
13 Mar 23
Regulation FD Disclosure
8:01am
8-K
2fvy60
9 Mar 23
Results of Operations and Financial Condition
4:02pm
8-K
ncxrzx67gqtnto vrp
29 Nov 22
ALX Oncology Appoints Scott Garland to its Board of Directors
9:11am
8-K
1b2xwl8c z6
8 Nov 22
ALX Oncology Reports Third Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
4:04pm
8-K
0wcoo nshdsm1bvh2g3c
31 Oct 22
ALX Oncology Enters $100 Million Loan Facility Agreement with Oxford Finance and Silicon Valley Bank to Support Ongoing Development of Evorpacept
7:30am
8-K
y0xm1531v6x
8 Aug 22
ALX Oncology Reports Second Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
4:03pm
8-K
1u5plzq p6reah91in
16 Jun 22
Submission of Matters to a Vote of Security Holders
4:14pm
8-K
zkr0dsb
9 May 22
ALX Oncology Reports First Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
4:04pm